{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:31:04Z","timestamp":1789115464757,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tranon.2026.102841","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:33:41Z","timestamp":1780371221000},"page":"102841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advanced radiotherapy and systemic therapy in head and neck adenoid cystic carcinoma: Current progress and future integrated strategies"],"prefix":"10.1016","volume":"70","author":[{"given":"Lihao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8505-0057","authenticated-orcid":false,"given":"Mingyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.tranon.2026.102841_bib0001","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.oraloncology.2015.04.005","article-title":"Adenoid cystic carcinoma of the head and neck\u2014an update","volume":"51","author":"Coca-Pelaz","year":"2015","journal-title":"Oral Oncol."},{"issue":"19","key":"10.1016\/j.tranon.2026.102841_bib0002","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/cncr.32208","article-title":"Minor salivary gland tumors of the head and neck\u2014Memorial Sloan Kettering experience: incidence and outcomes by site and histological type","volume":"125","author":"Hay","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2026.102841_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188523","article-title":"Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy","volume":"1875","author":"Nightingale","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"16","key":"10.1016\/j.tranon.2026.102841_bib0004","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/cncr.26740","article-title":"A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry","volume":"118","author":"Li","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.tranon.2026.102841_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/7401458","article-title":"Adenoid Cystic carcinoma of salivary glands: a ten-year review and an assessment of the current management, surgery, radiotherapy, and chemotherapy","volume":"2023","author":"Saleh","year":"2023","journal-title":"Int. J. Otolaryngol."},{"issue":"17","key":"10.1016\/j.tranon.2026.102841_bib0006","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.21.00449","article-title":"Management of salivary gland malignancy: ASCO guideline","volume":"39","author":"Geiger","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102841_bib0007","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.oraloncology.2013.05.004","article-title":"Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period","volume":"49","author":"van Weert","year":"2013","journal-title":"Oral Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102841_bib0008","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hed.23405","article-title":"Analysis of failure in patients with adenoid cystic carcinoma of the head and neck: an international collaborative study","volume":"36","author":"Amit","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2026.102841_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104466","article-title":"Advanced adenoid cystic carcinoma of the skull base\u2014the role of surgery","volume":"99","author":"Guazzo","year":"2019","journal-title":"Oral Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102841_bib0010","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.athoracsur.2020.11.033","article-title":"Effective radiotherapy in tracheobronchial adenoid cystic carcinoma with positive surgical margin","volume":"112","author":"Zhao","year":"2021","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.tranon.2026.102841_bib0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13005-020-00226-2","article-title":"Management of adenoid cystic carcinoma of the head and neck: a single-institute study with over 25-year follow-up","volume":"16","author":"Ishida","year":"2020","journal-title":"Head. Face Med."},{"issue":"10","key":"10.1016\/j.tranon.2026.102841_bib0012","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/MLG.0b013e31817fae29","article-title":"Facial nerve sacrifice and radiotherapy in parotid adenoid cystic carcinoma","volume":"118","author":"Iseli","year":"2008","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.tranon.2026.102841_bib0013","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/lary.27814","article-title":"The role of elective neck dissection in patients with adenoid cystic carcinoma of the head and neck","volume":"129","author":"Xiao","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.tranon.2026.102841_bib0014","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1741-7015-8-25","article-title":"Recent advances in radiotherapy","volume":"8","author":"Bhide","year":"2010","journal-title":"BMC. Med."},{"issue":"11","key":"10.1016\/j.tranon.2026.102841_bib0015","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.6004\/jnccn.2020.7593","article-title":"Role of postoperative radiotherapy in nonmetastatic head and neck adenoid cystic carcinoma","volume":"18","author":"Chen","year":"2020","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.tranon.2026.102841_bib0016","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2147\/CMAR.S283494","article-title":"Outcome of adenoid cystic carcinoma of head and neck after postoperative intensity modulation radiotherapy: a single institution study","volume":"Volume 13","author":"Xu","year":"2021","journal-title":"Cancer Manage Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102841_bib0017","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13014-022-02165-5","article-title":"Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck","volume":"17","author":"Choi","year":"2022","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102841_bib0018","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.21037\/qims-21-836","article-title":"Oncological outcomes of patients with salivary gland cancer treated with surgery and postoperative intensity-modulated radiotherapy: a retrospective cohort study","volume":"12","author":"Zang","year":"2022","journal-title":"Quant. Imaging Med. Surg."},{"issue":"21","key":"10.1016\/j.tranon.2026.102841_bib0019","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.3390\/cancers13215507","article-title":"Comparison of clinical outcomes of definitive and postoperative radiotherapy for adenoid cystic carcinoma of the head and neck: can definitive radiotherapy be a treatment option?","volume":"13","author":"Mizoguchi","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.tranon.2026.102841_bib0020","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1007\/s00405-021-06654-3","article-title":"Concurrent chemoradiotherapy for locally advanced unresectable adenoid cystic carcinoma of head and neck: experience from a single institute","volume":"278","author":"Swain","year":"2021","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"11","key":"10.1016\/j.tranon.2026.102841_bib0021","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.21037\/tcr-24-1221","article-title":"Comparison of postoperative radiotherapy and definitive radiotherapy for non-metastatic adenoid cystic carcinoma of the head and neck: a propensity score matching based on the SEER database","volume":"13","author":"Tan","year":"2024","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.tranon.2026.102841_bib0022","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2006.02.009","article-title":"Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy","volume":"78","author":"Fiorino","year":"2006","journal-title":"RadiOther Oncol."},{"key":"10.1016\/j.tranon.2026.102841_bib0023","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1748-717X-6-20","article-title":"Rotational IMRT techniques compared to fixed gantry IMRT and tomotherapy: multi-institutional planning study for head-and-neck cases","volume":"6","author":"Wiezorek","year":"2011","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102841_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semradonc.2023.10.003","article-title":"The use of MR-guided radiation therapy for head and neck cancer and recommended reporting guidance","volume":"34","author":"McDonald","year":"2024","journal-title":"Semin. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102841_bib0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.canrad.2020.01.008","article-title":"Head-and-neck MRI-only radiotherapy treatment planning: from acquisition in treatment position to pseudo-CT generation","volume":"24","author":"Largent","year":"2020","journal-title":"Cancer RadiOther"},{"issue":"245","key":"10.1016\/j.tranon.2026.102841_bib0026","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008973","article-title":"Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice","volume":"6","author":"Favaudon","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.tranon.2026.102841_bib0027","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/mp.12233","article-title":"Very high-energy electron (VHEE) beams in radiation therapy; treatment plan comparison between VHEE, VMAT, and PPBS","volume":"44","author":"Sch\u00fcler","year":"2017","journal-title":"Med. Phys."},{"issue":"6","key":"10.1016\/j.tranon.2026.102841_bib0028","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/1535-7163.MCT-23-0663","article-title":"Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer","volume":"23","author":"Chowdhury","year":"2024","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.tranon.2026.102841_bib0029","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ijrobp.2024.02.015","article-title":"Acute hypoxia does not alter tumor sensitivity to FLASH radiation therapy","volume":"119","author":"Leavitt","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.tranon.2026.102841_bib0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4143\/crt.2021.066","article-title":"Physical and biological characteristics of particle therapy for oncologists","volume":"53","author":"Byun","year":"2021","journal-title":"Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.tranon.2026.102841_bib0031","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/jpm11080825","article-title":"A critical review of radiation therapy: from particle beam therapy (proton, carbon, and BNCT) to beyond","volume":"11","author":"Matsumoto","year":"2021","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.tranon.2026.102841_bib0032","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.radonc.2016.08.020","article-title":"Benefit of particle therapy in re-irradiation of head and neck patients: results of a multicentric in silico ROCOCO trial","volume":"121","author":"Eekers","year":"2016","journal-title":"RadiOther Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102841_bib0033","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ctrv.2010.08.004","article-title":"Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons","volume":"37","author":"Ramaekers","year":"2011","journal-title":"Cancer Treat. Rev."},{"issue":"4219","key":"10.1016\/j.tranon.2026.102841_bib0034","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1188384","article-title":"Chromosome damage in liver cells from low dose rate alpha, beta, and gamma irradiation: derivation of RBE","volume":"190","author":"Brooks","year":"1975","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.tranon.2026.102841_bib0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.tranon.2026.102841_bib0036","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11684-012-0196-4","article-title":"Particle therapy for cancers: a new weapon in radiation therapy","volume":"6","author":"Jiang","year":"2012","journal-title":"Front. Med."},{"key":"10.1016\/j.tranon.2026.102841_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104752","article-title":"Clinical outcomes of head and neck adenoid cystic carcinoma patients treated with pencil beam-scanning proton therapy","volume":"107","author":"Pelak","year":"2020","journal-title":"Oral Oncol."},{"issue":"10","key":"10.1016\/j.tranon.2026.102841_bib0038","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/cancers11101413","article-title":"Proton beam therapy combined with intra-arterial infusion chemotherapy for stage IV adenoid cystic carcinoma of the base of the tongue","volume":"11","author":"Takayama","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2026.102841_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111143","article-title":"Prognostic factors and clinical outcomes in a large cohort of head and neck adenoid cystic carcinoma patients treated with proton beam therapy: insights from an Italian referral center","volume":"213","author":"Vischioni","year":"2025","journal-title":"RadiOther Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102841_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40880-018-0299-7","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun."},{"issue":"12","key":"10.1016\/j.tranon.2026.102841_bib0041","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.apradiso.2011.04.019","article-title":"The radiobiological principles of boron neutron capture therapy: a critical review","volume":"69","author":"Hopewell","year":"2011","journal-title":"Appl. Radiat. Isot."},{"issue":"3","key":"10.1016\/j.tranon.2026.102841_bib0042","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(99)00445-9","article-title":"Treatment of locally advanced adenoid cystic carcinoma of the head and neck with neutron radiotherapy","volume":"46","author":"Douglas","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.tranon.2026.102841_bib0043","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.oraloncology.2018.11.006","article-title":"The efficacy of neutron radiation therapy in treating salivary gland malignancies","volume":"88","author":"Timoshchuk","year":"2019","journal-title":"Oral Oncol."},{"issue":"Suppl 2","key":"10.1016\/j.tranon.2026.102841_bib0044","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03038884","article-title":"The application of PET to quality assurance of heavy-ion tumor therapy","volume":"175","author":"Enghardt","year":"1999","journal-title":"Strahlenther. Onkol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102841_bib0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/030089169808400217","article-title":"Radiotherapy with heavy ions: radiobiology, clinical indications and experience at GSI, Darmstadt","volume":"84","author":"Kraft","year":"1998","journal-title":"Tumori"},{"issue":"5","key":"10.1016\/j.tranon.2026.102841_bib0046","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jjco\/hyu010","article-title":"Particle radiotherapy using protons or carbon ions for unresectable locally advanced head and neck cancers with skull base invasion","volume":"44","author":"Morimoto","year":"2014","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102841_bib0047","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2017.11.010","article-title":"Multicenter study of carbon-ion radiation therapy for adenoid cystic carcinoma of the head and neck: subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) study (1402 HN)","volume":"100","author":"Sulaiman","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.tranon.2026.102841_bib0048","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/cancers11111705","article-title":"Treatment outcome of 227 patients with sinonasal adenoid cystic carcinoma after intensity modulated radiotherapy and active raster-scanning carbon ion boost: a 10-year single-center experience","volume":"11","author":"Akbaba","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2026.102841_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.593379","article-title":"Large German multicenter experience on the treatment outcome of 207 patients with adenoid cystic carcinoma of the major salivary glands","volume":"10","author":"Akbaba","year":"2020","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102841_bib0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2015.01.002","article-title":"Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy","volume":"114","author":"Jensen","year":"2015","journal-title":"RadiOther Oncol."},{"key":"10.1016\/j.tranon.2026.102841_bib0051","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2020.01.004","article-title":"Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO","volume":"145","author":"Vischioni","year":"2020","journal-title":"RadiOther Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102841_bib0052","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13014-019-1395-9","article-title":"Cost-effectiveness analysis of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma of the head and neck","volume":"14","author":"Jensen","year":"2019","journal-title":"Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102841_bib0053","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hed.26941","article-title":"Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: cost-effectiveness analysis","volume":"44","author":"Li","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2026.102841_bib0054","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2340\/1651-226X.2025.42209","article-title":"Distinct patterns of osteoradionecrosis after photon-based radiotherapy and carbon ion radiotherapy for unresectable adenoid cystic carcinoma of the head and neck: case series from two institutions","volume":"64","author":"Storaas","year":"2025","journal-title":"Acta Oncol."},{"issue":"19","key":"10.1016\/j.tranon.2026.102841_bib0055","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.tranon.2026.102841_bib0056","first-page":"4092","article-title":"Systemic therapies for salivary gland adenoid cystic carcinoma","volume":"11","author":"Sahara","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.tranon.2026.102841_bib0057","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.annonc.a010684","article-title":"Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma: a phase II trial of 22 patients","volume":"7","author":"Licitra","year":"1996","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102841_bib0058","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/COC.0000000000000112","article-title":"Cisplatin+vinorelbine treatment of recurrent or metastatic salivary gland malignancies: a final report on 60 cases","volume":"40","author":"Airoldi","year":"2017","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102841_bib0059","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hed.24933","article-title":"Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and\/or metastatic salivary gland cancer of the head and neck","volume":"40","author":"Hong","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2026.102841_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109891","article-title":"A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy","volume":"188","author":"Hsieh","year":"2023","journal-title":"RadiOther Oncol."},{"key":"10.1016\/j.tranon.2026.102841_bib0061","article-title":"Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: a propensity score matched analysis","volume":"53","author":"Dou","year":"2025","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102841_bib0062","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hed.10104","article-title":"Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin","volume":"24","author":"Vered","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2026.102841_bib0063","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1748-717X-5-102","article-title":"Radioimmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab","volume":"5","author":"Jensen","year":"2010","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102841_bib0064","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijrobp.2019.09.036","article-title":"The phase 1\/2 ACCEPT trial: concurrent cetuximab and intensity modulated radiation therapy with carbon ion boost for adenoid cystic carcinoma of the head and neck","volume":"106","author":"Adeberg","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"25","key":"10.1016\/j.tranon.2026.102841_bib0065","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.2007.11.8612","article-title":"Phase II study of lapatinib in recurrent or metastatic EGFR and\/or erbB2 expressing adenoid cystic carcinoma and non\u2013adenoid cystic carcinoma malignant tumors of the salivary glands","volume":"25","author":"Agulnik","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102841_bib0066","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hed.23647","article-title":"Phase II study of gefitinib in patients with advanced salivary gland cancers","volume":"37","author":"Jakob","year":"2015","journal-title":"Head Neck"},{"issue":"7","key":"10.1016\/j.tranon.2026.102841_bib0067","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.oraloncology.2008.07.010","article-title":"Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study","volume":"45","author":"Locati","year":"2009","journal-title":"Oral Oncol."},{"issue":"18","key":"10.1016\/j.tranon.2026.102841_bib0068","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.18.01859","article-title":"Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma","volume":"37","author":"Tchekmedyian","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102841_bib0069","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/hed.23577","article-title":"Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck","volume":"37","author":"Thomson","year":"2015","journal-title":"Head Neck"},{"issue":"7","key":"10.1016\/j.tranon.2026.102841_bib0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaoto.2024.1177","article-title":"Vascular endothelial growth factor receptor inhibitors for recurrent or metastatic adenoid cystic carcinoma: a systematic review and meta-analysis","volume":"150","author":"Hoff","year":"2024","journal-title":"JAMA Otolaryngol. Head. Neck. Surg."},{"key":"10.1016\/j.tranon.2026.102841_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103886","article-title":"Drug-based therapy for advanced adenoid cystic carcinoma: current landscape and challenges based on an overview of registered clinical trials","volume":"181","author":"Wagner","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102841_bib0072","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41416-024-02795-4","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade","volume":"131","author":"Zhou","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.tranon.2026.102841_bib0073","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1038\/s41591-023-02518-x","article-title":"Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial","volume":"29","author":"Vos","year":"2023","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.tranon.2026.102841_bib0074","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s43018-025-00905-6","article-title":"FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy","volume":"6","author":"Ni","year":"2025","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2026.102841_bib0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2022.12.018","article-title":"Proton FLASH radiation therapy and immune infiltration: evaluation in an orthotopic glioma rat model","volume":"116","author":"Iturri","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.tranon.2026.102841_bib0076","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10637-019-00739-x","article-title":"Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma","volume":"38","author":"Even","year":"2020","journal-title":"Invest. New Drugs"},{"issue":"5","key":"10.1016\/j.tranon.2026.102841_bib0077","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70663","article-title":"Clinical outcomes with Notch inhibitors in Notch-activated recurrent\/metastatic adenoid cystic carcinoma","volume":"14","author":"Hoff","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2026.102841_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106634","article-title":"PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: an open-label, phase I dose-expansion study","volume":"149","author":"Ferrarotto","year":"2024","journal-title":"Oral Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102841_bib0079","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/jop.70008","article-title":"TROP2 Expression in salivary gland adenoid cystic carcinoma (ACC) according to histologic subtype: therapeutic implications","volume":"54","author":"Siqueira","year":"2025","journal-title":"J. Oral Pathol. Med."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:35:24Z","timestamp":1789112124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":79,"alternative-id":["S1936523326001786"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102841","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced radiotherapy and systemic therapy in head and neck adenoid cystic carcinoma: Current progress and future integrated strategies","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102841"}}